These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 13680252

  • 1. Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behçet's disease: a case report.
    Krause L, Hoffmann F, Zouboulis CC, Foerster MH.
    Graefes Arch Clin Exp Ophthalmol; 2003 Oct; 241(10):871-4. PubMed ID: 13680252
    [Abstract] [Full Text] [Related]

  • 2. Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Behçet's disease.
    Krause L, Altenburg A, Bechrakis NE, Willerding G, Zouboulis CC, Foerster MH.
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1617-21. PubMed ID: 17431663
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.
    Kötter I, Zierhut M, Eckstein A, Vonthein R, Ness T, Günaydin I, Grimbacher B, Blaschke S, Peter HH, Kanz L, Stübiger N.
    Adv Exp Med Biol; 2003 Nov; 528():521-3. PubMed ID: 12918755
    [No Abstract] [Full Text] [Related]

  • 7. Interferon alfa-2a in the treatment of ocular Adamantiades-Behçet's disease.
    Krause L, Turnbull JR, Torun N, Pleyer U, Zouboulis CC, Foerster MH.
    Adv Exp Med Biol; 2003 Nov; 528():511-9. PubMed ID: 12918754
    [No Abstract] [Full Text] [Related]

  • 8. Methotrexate in ocular manifestations of Behcet's disease: a longitudinal study up to 15 years.
    Davatchi F, Shams H, Shahram F, Nadji A, Chams-Davatchi C, Sadeghi Abdollahi B, Faezi T, Akhlaghi M, Ashofteh F.
    Int J Rheum Dis; 2013 Oct; 16(5):568-77. PubMed ID: 24164845
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of retinal vasculitis in Behçet's disease with rituximab.
    Sadreddini S, Noshad H, Molaeefard M, Noshad R.
    Mod Rheumatol; 2008 Oct; 18(3):306-8. PubMed ID: 18438602
    [Abstract] [Full Text] [Related]

  • 11. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years.
    Davatchi F, Sadeghi Abdollahi B, Shams H, Shahram F, Nadji A, Chams-Davatchi C, Faezi T, Akhlaghi M, Ghodsi Z, Ashofteh F, Mohtasham N.
    Int J Rheum Dis; 2014 May; 17(4):444-52. PubMed ID: 24314325
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease.
    Adler YD, Mansmann U, Zouboulis CC.
    Dermatology; 2001 May; 203(4):322-4. PubMed ID: 11752821
    [Abstract] [Full Text] [Related]

  • 13. [Eye and Behçet's disease].
    Ksiaa I, Abroug N, Kechida M, Zina S, Jelliti B, Khochtali S, Attia S, Khairallah M.
    J Fr Ophtalmol; 2019 Jun; 42(6):626-641. PubMed ID: 31164292
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a].
    Deuter CM, Kötter I, Günaydin I, Zierhut M, Stübiger N.
    Ophthalmologe; 2004 Feb; 101(2):129-34. PubMed ID: 14991308
    [Abstract] [Full Text] [Related]

  • 16. Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment.
    Deuter CM, Kötter I, Günaydin I, Zierhut M, Stübiger N.
    Adv Exp Med Biol; 2003 Feb; 528():525-8. PubMed ID: 12918756
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Complete regression of retinal neovascularization after therapy with interferon alfa in Behçet's disease.
    Stuebiger N, Koetter I, Zierhut M.
    Br J Ophthalmol; 2000 Dec; 84(12):1437-8. PubMed ID: 11186866
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.
    Kötter I, Eckstein AK, Stübiger N, Zierhut M.
    Br J Ophthalmol; 1998 May; 82(5):488-94. PubMed ID: 9713053
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.